BioSig Technologies' Common Stock To Resume Trading On The Nasdaq Exchange, Wednesday, October 23, 2024 After Its Appeal Was Granted An Extension Until March 7, 2025
Portfolio Pulse from Benzinga Newsdesk
BioSig Technologies' common stock will resume trading on the NASDAQ Capital Market Exchange on October 23, 2024, after a successful appeal granted an extension until March 7, 2025, to meet the Market Value of Listed Securities requirement.
October 22, 2024 | 7:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BioSig Technologies' stock will resume trading on NASDAQ on October 23, 2024, following a successful appeal for an extension to meet MVLS requirements.
The resumption of trading on NASDAQ is a positive development for BioSig Technologies, as it indicates regulatory compliance and provides liquidity and visibility to investors. The extension until March 7, 2025, allows the company time to meet the MVLS requirement, reducing immediate delisting risk.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100